- Supported exchanges /
- F /
- 6K9.F
CONTEXT THERAPEUT.DL-001 (6K9 F) stock market data APIs
Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. Context Therapeutics Inc. was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
CONTEXT THERAPEUT.DL-001 Financial Data Overview
| 1.93 | |
| 2.04 | |
| - | |
| 2.04 | |
| 1.93 | |
| 0.685-2.4 | |
| 155 M | |
| 74 998 K | |
| 0 | |
| 2.272 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
CONTEXT THERAPEUT.DL-001 Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -20 014 956
- Earnings Per Share -0.89
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get CONTEXT THERAPEUT.DL-001 Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get CONTEXT THERAPEUT.DL-001 End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
